Campbell & CO Investment Adviser LLC Ardelyx, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 15,727 shares of ARDX stock, worth $83,824. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,727
Previous 38,099
58.72%
Holding current value
$83,824
Previous $262,000
69.08%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$130 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$93.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$76.6 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$61.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$55.1 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $824M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...